. Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9289-94. Epub 2014 Jun 9 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Research Models

  1. Lrrk2 KO Rat

Therapeutics

  1. DNL151
  2. DNL201

News

  1. LRRK2 Inhibitor Hits Target, Appears Safe for Parkinson’s